Mode
Text Size
Log in / Sign up
N/A N=3,087 Randomized Single-blind Treatment

Spine Pain INtervention to Enhance Care Quality And Reduce Expenditure

Back Pain · Neck Pain

Enrolled (actual)
3,087
Serious AEs
Results posted
Sep 2025
Primary outcome: Primary: Spine-related Cost of Care at One Year — 1587; 1448; 2528 dollars — p=.04

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Identify, Coordinated, Enhanced (ICE) Decision Making + PCP led care (Other); Individualized Postural Therapy (IPT) + PCP led care (Other); Usual PCP led care (Other)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
Brigham and Women's Hospital
Primary completion
Mar 2021

Outcome Measures

OutcomeResultp-value
PRIMARY
Spine-related Cost of Care at One Year
1587; 1448; 2528 .04 sig
PRIMARY
Change in Pain
-9.2; -17.7; -16.3 <0.001 sig
SECONDARY
Change in Pain
-9.2; -17.7; -16.3 <0.001 sig
SECONDARY
Quality of Life (EQ5D-5L VAS Scores)
3.2; 8.9; 10.5 <0.001 sig
SECONDARY
Self-efficacy
-1.0; 7.4; 6.4 <0.001 sig

Summary

Low back and neck pain are among the leading causes of medical visits, lost productivity and disability. There is an urgent need to identify effective and efficient ways of helping subjects with acute spine pain while guiding practitioners towards high-value care. This trial will be a block and cluster-randomized open-label multi-centered pragmatic randomized clinical trial comparing healthcare spending and clinical outcomes for subjects with spine pain of less than three months' duration, in whom there are no red flag signs or symptoms. Subjects will be randomized to one of three treatment strategies: (1) usual primary care provider-led care; (2) usual PCP-led care with spine pain treatment directed by the Identify, Coordinate, and Enhanced decision making (ICE) care model, and (3) usual PCP-led care with spine pain treatment directed by the Individualized Postural Therapy (IPT) care model. Our outcomes of interest will be spine-related healthcare utilization at one year as well as pain and functionality of the study participants.

Eligibility Criteria

Inclusion Criteria

  • Patients with back or neck pain of ≤ 3 months' duration. All patients must have spine pain with or without radiation to the extremities or the head
  • Age ≥ 18 years
  • Willing and able to provide informed consent

Exclusion Criteria

  • Patients with symptoms attributed to the spine but without actual pain in the spine (e.g. those with cervicogenic headache without neck pain)
  • Currently pregnant
  • Currently receiving disability benefits, worker's compensation, or involved in litigation for a workplace injury
  • Currently enrolled in another intervention trial for the management of acute back or neck pain
  • Cancer that is metastatic or being actively treated. (i.e chemotherapy, radiation, surgery)
  • History of receiving active therapy for back or neck pain in the past 3 months (7+ consecutive days of narcotic use, 6+ sessions of PT, chiropractic care, acupuncture, postural therapy, or other spine therapy delivered by a trained provider)
  • History of spine surgery or spine injections/ablation in the past 6 months
  • Severe, active psychosis or major depression inhibiting ability to physically participate in intervention
  • Red Flag Symptoms (fever, night sweats, unintentional weight loss, bowel or bladder dysfunction, neurologic weakness, history of intravenous drug use)
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03083886). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search